Boston Scientific Corp. (BSX) Misses Q2 EPS by 1c
Tweet
Share
E-mailGet Alerts BSX Hot Sheet
Price: $44.95 -0.75%
Revenue Growth %: +6.3%
Financial Fact:
Net income (loss): 228M
Today's EPS Names:
OCCI, MAYS, CRMT, More
Revenue Growth %: +6.3%
Financial Fact:
Net income (loss): 228M
Today's EPS Names:
OCCI, MAYS, CRMT, More
Join SI Premium – FREE
Boston Scientific Corp. (NYSE: BSX) reported Q2 EPS of $0.18, $0.01 worse than the analyst estimate of $0.19. Revenue for the quarter came in at $1.87 billion versus the consensus estimate of $1.87 billion.
For earnings history and earnings-related data on Boston Scientific Corp. (BSX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Ennis (EBF) Reports In-Line Q1 EPS
- Qtrex Quantum executives plan to buy up to 2M shares over 12 months
- Evercore ISI Starts Credo Tech (CRDO) at Outperform
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
